In addition, most of the drugs listed in Table 1 reduce exhaustion in CD8+ T cells, hinting at their ability to rejuvenate intra-tumoral CD8+ T cells; by adopting a methionine-restricted and ketogenic diet in combination with these metabolism-regulating drugs, anti-tumor responses could potentially be enhanced upon ICB therapy in patients with cancer. Here, CD8A is linked to cancer.